Candel Therapeutics (CADL) Q3 2025 Earnings

Aug 14Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.4
-0.22
-0.05
0.13

Details

Expected EPS
-0.1637
Actual EPS
-0.09
Surprise EPS
0.07
Surprise Percent
+45.02%

Description

⁨Candel Therapeutics⁩ (⁦CADL⁩) has reported earnings of ⁦-0.09⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts